Status:

NOT_YET_RECRUITING

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Lead Sponsor:

Peking University People's Hospital

Conditions:

Elderly

Geriatric Assessment

Eligibility:

All Genders

55+ years

Brief Summary

This comprehensive, multidimensional evaluation assesses patient-related factors, disease-related factors, donor-related factors, and treatment-related factors. The study aims to identify potential ri...

Detailed Description

This comprehensive, multidimensional evaluation assesses patient-related factors (e.g., age, physical function, and comorbidity index), disease-related factors (e.g., primary diagnosis and blast count...

Eligibility Criteria

Inclusion

  • (a)Age ≥55 years.
  • (b)Hematologic disorders with established indications for transplantation, including malignant and non-malignant hematologic diseases. (c)Willingness to provide informed consent.

Exclusion

  • (a)Pregnancy. (b) Uncontrolled active infection. (c) Lack of informed consent. (d)Deemed ineligible for transplantation after investigator assessment

Key Trial Info

Start Date :

May 20 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

176 Patients enrolled

Trial Details

Trial ID

NCT06946654

Start Date

May 20 2025

End Date

March 31 2027

Last Update

May 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking University People's Hospital

Beijing, China